# OSELTAMIVIR

NDC: 46708-413
Generic name: OSELTAMIVIR
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20190625

FDA application: ANDA211823

## Active ingredients

- OSELTAMIVIR PHOSPHATE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-413"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-413
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a7181a6-e9eb-4047-a26f-4268f174db16